Feasibility study of sentinel lymph node biopsy in oral and laryngo-pharyngeal cancer patients using an indocyanine green fluorescence method and a radioisotope method.

Feasibility study of sentinel lymph node biopsy in oral and laryngo-pharyngeal cancer patients using an indocyanine green fluorescence method and a radioisotope method. - Sentinel lymph node biopsy in oral and pharyngo-laryngeal cancer patients using an ICG fluorescence method and a RI method.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006509

Enrollment

Registered

2011-10-12

Start date

2011-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral and pharyngo-laryngeal cancer

Interventions

We perform the sentinel node lymph node biopsy metastasis in head and neck cancer patients using an ICG fluorescence method and a RI method.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Previously untreated and clinically negative neck oral (late T2 and T3) and laryngo-pharyngeal (T1-T3) squamous cell carcinoma patients are the candidates for our study.

Exclusion criteria

Exclusion criteria: 1)Previously treated patients 2)A history of radiation therapy for the neck 3)Pregnancy or lactating women, or women with suspected pregnancy

Design outcomes

Primary

Measure	Time frame
We focus on the accuracy of detecting of sentinel nodes using an ICG fluorescence method.	—

Countries

Japan

Contacts

Public ContactYasuhisa Hasegawa

Aichi Cancer Center Department of Head and Neck Surgery

hasegawa@aichi-cc.jp052-762-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026